BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16804917)

  • 21. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma.
    Sanchez-Izquierdo D; Buchonnet G; Siebert R; Gascoyne RD; Climent J; Karran L; Marin M; Blesa D; Horsman D; Rosenwald A; Staudt LM; Albertson DG; Du MQ; Ye H; Marynen P; Garcia-Conde J; Pinkel D; Dyer MJ; Martinez-Climent JA
    Blood; 2003 Jun; 101(11):4539-46. PubMed ID: 12560219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Frequency of genetic aberrations in mucosa-associated lymphoid tissue lymphoma of different sites].
    Li BZ; Lu HF; Zhou XY; Yang WT; Kong YY; Fan YZ; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):604-8. PubMed ID: 19094584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
    Hosokawa Y
    Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB; Samuel T; Reed JC
    Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
    Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.
    Zhou H; Du MQ; Dixit VM
    Cancer Cell; 2005 May; 7(5):425-31. PubMed ID: 15894263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
    Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
    J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
    Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
    Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
    Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ
    Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of API2-MALT1 fusion gene in extranodal B-cell lymphoma and its significance].
    Yang WX; Li GD; Zhou Q; Liu WP; Li L; Chen N
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):92-6. PubMed ID: 16630483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas.
    Murga Penas EM; Hinz K; Röser K; Copie-Bergman C; Wlodarska I; Marynen P; Hagemeijer A; Gaulard P; Löning T; Hossfeld DK; Dierlamm J
    Leukemia; 2003 Nov; 17(11):2225-9. PubMed ID: 12931213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation.
    Hosokawa Y; Suzuki H; Nakagawa M; Lee TH; Seto M
    Biochem Biophys Res Commun; 2005 Aug; 334(1):51-60. PubMed ID: 15982633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
    Rosebeck S; Lucas PC; McAllister-Lucas LM
    Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
    Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
    Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
    Stoffel A; Le Beau MM
    Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.
    Vicente-Dueñas C; Fontán L; Gonzalez-Herrero I; Romero-Camarero I; Segura V; Aznar MA; Alonso-Escudero E; Campos-Sanchez E; Ruiz-Roca L; Barajas-Diego M; Sagardoy A; Martinez-Ferrandis JI; Abollo-Jimenez F; Bertolo C; Peñuelas I; Garcia-Criado FJ; García-Cenador MB; Tousseyn T; Agirre X; Prosper F; Garcia-Bragado F; McPhail ED; Lossos IS; Du MQ; Flores T; Hernandez-Rivas JM; Gonzalez M; Salar A; Bellosillo B; Conde E; Siebert R; Sagaert X; Cobaleda C; Sanchez-Garcia I; Martinez-Climent JA
    Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10534-9. PubMed ID: 22689981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The translocations t(6;18;11)(q24;q21;q21) and t(11;14;18)(q21;q32;q21) lead to a fusion of the API2 and MALT1 genes and occur in MALT lymphomas.
    Murga Penas EM; Callet-Bauchu E; Ye H; Hinz K; Albert N; Copie-Bergman C; Gazzo S; Berger F; Salles G; Bokemeyer C; Du MQ; Dierlamm J
    Haematologica; 2007 Mar; 92(3):405-9. PubMed ID: 17339192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
    Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
    J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21).
    Zhou Y; Ye H; Martin-Subero JI; Hamoudi R; Lu YJ; Wang R; Siebert R; Shipley J; Isaacson PG; Dogan A; Du MQ
    Br J Haematol; 2006 Apr; 133(1):35-42. PubMed ID: 16512826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
    Okabe M; Inagaki H; Ohshima K; Yoshino T; Li C; Eimoto T; Ueda R; Nakamura S
    Am J Pathol; 2003 Apr; 162(4):1113-22. PubMed ID: 12651604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.